CAR-T cells targeting CD20 or CD22 under R/R conditions have been investigated, albeit in preliminary stages.10,11,35,36 Other potential targets for various lymphoma types include CD30,37 k-light chain (Table 1),38 and receptor-tyrosine-kinase-like orphan receptor 1 (ROR1). Here, CD22 is linked to lymphoma.